Segments 7 codes for M1 and M2 proteins (Matrix proteins)

Similar documents
2009 (Pandemic) H1N1 Influenza Virus

Preparing for the Fall Flu Season. Jonathan Gubbay Medical Microbiologist Public Health Laboratory OAHPP

Evolution of influenza

Influenza. Gwen Clutario, Terry Chhour, Karen Lee

Ralph KY Lee Honorary Secretary HKIOEH

Pandemic H1N1 2009: The Public Health Perspective. Massachusetts Department of Public Health November, 2009

Lecture 19 Evolution and human health

Current Vaccines: Progress & Challenges. Influenza Vaccine what are the challenges?

H1N1 Influenza. Influenza-A Basics. Influenza Basics. April 1, History of Influenza Pandemics. April 1 September 25, 2009

Outline. Seasonal Influenza & Pneumonia National & State Statistics Novel Influenza A H1N1

Conflict of Interest and Disclosures. Research funding from GSK, Biofire

Situation Update Pandemic (H1N1) August 2009

Patricia Fitzgerald-Bocarsly

University of Colorado Denver. Pandemic Preparedness and Response Plan. April 30, 2009

Influenza: The Threat of a Pandemic

INFLUENZA-2 Avian Influenza

Phylogenetic Methods

Human Cases of Swine Influenza in California, Kansas, New York City, Ohio, Texas, and Mexico Key Points April 26, 2009

2009 H1N1 (Pandemic) virus IPMA September 30, 2009 Anthony A Marfin

Influenza A Viruses (Evolution and Current Status) AND H3N2v Outbreak Update

Pandemic Influenza Preparedness

Before and during influenza pandemics

Incidence of Seasonal Influenza

Weekly Influenza Surveillance Report. Week 11

Buy The Complete Version of This Book at Booklocker.com:

Introduction to Avian Influenza

Influenza: The past, the present, the (future) pandemic

Overview of the Influenza Virus

Influenza viruses. Virion. Genome. Genes and proteins. Viruses and hosts. Diseases. Distinctive characteristics

Caribbean Actuarial Association

ph1n1 H3N2: A Novel Influenza Virus Reassortment

Influenza. Paul K. S. Chan Department of Microbiology The Chinese University of Hong Kong

Influenza 2009: Not Yet The Perfect Storm

Influenza B viruses are not divided into subtypes, but can be further broken down into different strains.

WHO Technical Consultation on the severity of disease caused by the new influenza A (H1N1) virus infections

A/H1N influenza in Israel: Preparedness and response

In April 2009, a new strain of

Zoonotic potential of non-avian influenza A viruses

VIROLOGY OF INFLUENZA. Subtypes: A - Causes outbreak B - Causes outbreaks C - Does not cause outbreaks

PANDEMIC INFLUENZA PREPAREDNESS: STATE CHALLENGES

PUBLIC HEALTH SIGNIFICANCE SEASONAL INFLUENZA AVIAN INFLUENZA SWINE INFLUENZA

دکتر بهروز نقیلی استاد بیماریهای عفونی مرکس تحقیقات بیماریهای عفونی و گرمسیری پاییس 88

H1N1 Response and Vaccination Campaign

Prevention of Human Swine Influenza International perspectives

Pandemic Influenza: Hype or Reality?

4.3.9 Pandemic Disease

Novel H1N1 Influenza. It s the flu after all! William Muth M.D. Samaritan Health Services 9 November 2009

Novel H1N1 Influenza A: Protecting the Public

ECMO and the 2013 Influenza A H1N1 Epidemic

SWINE FLU 3: NOW NAMED H1N1 INFLUENZA A

Influenza. By Allison Canestaro-Garcia. Disease Etiology:

Pandemic H1N Dr. Maria Neira Global Influenza Programme WHO, Geneva

Influenza Pandemic Preparedness for Clinicians on the Frontline

Emerging Infections: Pandemic Influenza. W. Paul Glezen

Influenza. Tim Uyeki MD, MPH, MPP, FAAP

Influenza A 6/23/2010. Lisa Winston, MD UCSF / San Francisco General Hospital Divisions of Infectious Diseases and Hospital Medicine

Avian influenza Avian influenza ("bird flu") and the significance of its transmission to humans

Influenzavirus. Influenzavirus 10/27/15. Lord Randolphs report from Queen Marys trip to Scotland in 1562

OIE Situation Report for Highly Pathogenic Avian Influenza

The Influenza A (H1N1

NOVEL H1N1 INFLUENZA EPIDEMIC: Lessons From A Tertiary Centre In Bangalore

Q: If antibody to the NA and HA are protective, why do we continually get epidemics & pandemics of flu?

INFLUENZA VIRUS. INFLUENZA VIRUS CDC WEBSITE

Influenza A H1N1 Swine Flu Update:

DRAFT WGE WGE WGE WGE WGE WGE WGE WGE WGE WGE WGE WGE WGE WGE GETREADYNOWGE GETREADYNOWGE GETREADYNOWGE GETREADYNOWGE.

HS-LS4-4 Construct an explanation based on evidence for how natural selection leads to adaptation of populations.

This Week in Virology. Special Episode. Interview with Dr. Peter Palese

What is Influenza? Patricia Daly MD, FRCPC Medical Health Officer and Medical Director of Communicable Disease Control

OIE Situation Report for Highly Pathogenic Avian Influenza

ORTHOMYXOVIRUSES INFLUENZA VIRUSES. (A,B and C)

ORIGINAL ARTICLE INFLUENZA A (H1N1) PANDEMIC: PAHANG EXPERIENCE ABSTRACT INTRODUCTION

Pandemic Influenza: Global and Philippine Situation

Swine influenza surveillance among pigs in Nan Province

Review of diagnostic tests for SIV s and pandemic H1N1 in pigs. Ian Brown. Veterinary Laboratories Agency- Weybridge

Global updates on avian influenza and tools to assess pandemic potential. Julia Fitnzer Global Influenza Programme WHO Geneva

Devon Community Resilience. Influenza Pandemics. Richard Clarke Emergency Preparedness Manager Public Health England South West Centre

SEA/CD/154 Distribution : General. Avian Influenza in South-East Asia Region: Priority Areas for Research

abcdefghijklmnopqrstu

Origins and evolutionary genomics of the novel avian-origin H7N9 influenza A virus in China: Early findings

Acute respiratory illness This is a disease that typically affects the airways in the nose and throat (the upper respiratory tract).

The A(H7N9) influenza outbreak in China

Influenza. Paul K. S. Chan Department of Microbiology The Chinese University of Hong Kong

Lecture 18 Evolution and human health

Avian Influenza (Bird Flu) Fact Sheet

Influenza Viruses A Review

Modeling the Antigenic Evolution of Influenza Viruses from Sequences

H1N1 Flu Virus Sudbury & District Health Unit Response. Shelley Westhaver May 2009

Agricultural Outlook Forum Presented: February 16, 2006 THE CURRENT STATE OF SCIENCE ON AVIAN INFLUENZA

Lesson 20 Study Guide: Medical Biotechnology Pandemic Flu & Emergent Disease

Where Health Care Meets Policy. with Dr. Mike Magee

Influenza A(H1N1)2009 pandemic Chronology of the events in Belgium

Epidemiology Treatment and control Sniffles and Sneezes Mortality Spanish flu Asian flu Hong Kong flu The Swine flu scare

Epidemiological Situation on Pandemic Influenza H1N in the World and in Japan

Pandemic Influenza. Bradford H. Lee, MD Nevada State Health Officer. Public Health: Working for a Safer and Healthier Nevada

A Just in Time Primer on H1N1 Influenza A and Pandemic Influenza developed by the National Association of State EMS Officials and Revised by the

USDA Surveillance for Influenza A Virus in Swine: Summary of Results

Viruses: Select Agents and Emerging Pathogens. Patricia Bolívar MS., CLS, PHM

Influenza: A Challenge?

Pandemic Influenza influenza epidemic: realization of a worst-case scenario

Influenza Update N 157

Transcription:

One Flu over the Cuckoo s nest Dr Rachel Jones Department of Virology NPHS Microbiology Cardiff Whistlestop tour through Flu The virus Some history The Novel Virus Recent events The disease The control measures The laboratory tests The Future Disease which sound like flu have been described since 400 BC Influenza comes from the word Influentia because it was believed that diseases were caused by bad heavenly fluids or influence. Diseases were described as influenza di catarro was a bad head cold with lots of catarrah. Segments 1,3,4,5 and 6 code for single proteins 1 and 3 = parts of transcription complex 4 = Haemaglutinin (16) H1,H2,H3 H5, H7, H9 5 = Nucleoprotein Capsid 6 = Neuraminidase (9) N1,N2 N3 Segments 2 codes for PB1 + PB1-F2 PB1 = Transcription complex PB1-F2 apoptosis Segments 7 codes for M1 and M2 proteins (Matrix proteins) Segment 8 codes for NS1 (IFN antagonist) NS2 (Exporter or ribonucleoproteins out of nucleus) What makes the viruses more pathogenic? Multiple genes determine pathogenicity: HA receptors bindings sites widespread or localised to upper respiratory tract HA cleavage protease c PB1-F2 - (apoptosis) high virus titres production of cytokines = more severe infections NS1 modulates host cell innate immune response Point mutations can result in dramatic changes to pathogenicity 1

Lessons learnt from the past. 1918 Spanish Flu H1N1 1957 Asian Flu H2N2 1968 Hong Kong Flu H3N2?? Next pandemic H1N1 H2N2 H1N1 Avian Human Reassortment H3 H2N2 Avian Human Reassortment? All 8 RNA segments from birds 3 Avian 5 human (1918) 2 new Avian 5 human (1918) Swine influenza Viruses Triple reassortant swine flu viruses Found in pigs since 1998 (enzootic) in North American pigs Dec 2005- Feb 2009 11/12 sporadic humans infections 9 patients had exposure to pigs? 1 cases of humanhuman transmission. 11/12 recovered 4 hospitalised 50 human cases of swine flu reported since 1970 s worldwide (7 deaths) Triple Re-assortant virus - Pigs PB2 PB1 PA HA NP NA M NS Classic swine North America Avian North America Seasonal H3N2 Eurasian swine lineage Novel swine H1N1 Humans Found in Humans not pigs It is a NEW virus this combination of genes has not been seen before 11 th March 1 st case retrospectively ID 18 th March Mexican surveillance notes increase in flu like illness 28 th March 9 yr old girl OPD flu surveillance ( Imperial County Ca) 30 th March 10 year old boy admitted with fever ( San Diego) 1 st April found to be flu A not typable 6 th April news breaks of problem in Mexico 7 th April Mexican National Inst of Respiratory disease starts investigating clusters 10 th April Pan American Health notes news 11 th April WHO as pandemic alert response network - asks what s happening in Mexico 16 th April 10 year old boy confirmed as H1N1 27 th April Canada and Spain confirm cases 28 th April 7 countries confirm cases 29 th WHO raises pandemic to phase 5 1 st May 13 countries report cases 5 th May 1 st Death in America / 11 th March ID 13 th May WHO discuss severity index 15 th May 100,000 USA clinical cases far greater than those confirmed with H1N1 20 th May Vaccine production mid July 22 nd May WHO claims to be thinking pandemic phases more consideration given to severity of disease?? WHO to declare pandemic?? 2

What s Happening today? Why the Fuss? UK 405 confirmed cases 313 England 88 Scotland 2 Ireland 2 Wales Worldwide 21940 confirmed 125 deaths (103 Mexico 17 USA) H1N1 is a new virus; it hasn t been seen before in man or animals Mild pandemics cause disruption Concerns that virus may change Globalisation different countries affected differently Increase in chronic disease burden Pandemics what we know Shift in the Virus subtype Attacks / Death rates higher in younger people Higher transmissibility cf seasonal flu Different impact in different geographic regions Successive waves of infection What do we know so far Mexico, USA, Canada, Spain Male:female 50:50 Mild illness outside of Mexico Median age 20-30yrs Mortality 0.56% (Incl Mexico) 0.10% (Exc Mexico) (2.5 4% 1918) Mummy are we all going to die of Swine Flu? Hospitalised patients-california 30 patient (553cases) 26 confirmed 4 probable 50% San Diego Age range 27-89 Median 27.5 years 70% female 65% Hispanic MMWR 22/05/09 58 (19) 536-41 64% Chronic conditions 20% ITU (80% Ventilated) 17% (5/30)pregnant 2 lost fetus 27% Vaccinated 3

Pandemics what we know Containment What happening in the labs? Shift in the Virus subtype Attacks / Death rates higher in younger people Higher transmissibility cf seasonal flu Different impact in different geographic regions Successive waves of infection Time will tell! To buy time Vaccine development Ensure plans in place Gain understanding about the virus Has it worked? Problems Case definition Work load Compliance Testing Is it sustainable?? MITIGATION NAAT tests: NASBA Nucleoprotein (A) TAQMAN CDC Atlanta Matrix (A) CFI (Swine generic) CDC Atlanta (HSW) Neuraminidase N1 Seasonal Flu DIF POCT Immunity?Vaccination? MMWR 22 May 09 58(19) 521-534 6-9% adults (18-64) had some cross reactivity 33% >60yrs had some cross reactivity After vaccination 18-64 had 12-18x in titre to seasonal Flu but no real increase against Novel Virus Conclusion Susceptible population Severity of illness Where does that come in the plan? 4

Vaccination Vaccination Lessons learnt Benefit 4.9 billion doses can be available in 12 months USA 90 million UK 45 million people Risk Risk The dangers of a new vaccine Stopping the production of seasonal vaccine Monovalent plus triple valent Costs! Benefit Vaccine works how well? but Will it be in time Is the virus severe enough to warrant the risks? Is this the pandemic? Pandemics plans need to be tested Laboratory reserves stretched Transport issues Teamworking Communication Duration! goodwill only lasts for so long. Politics needs vs health protection International cooperation needs to continue. Rapidity of gaining knowledge, sharing knowledge A lot of the infrastructure was in place HPA The future 5

Acknowledgements Catherine Moore and Sally Corden Staff of the molecular lab Cardiff Staff of the virology lab Cardiff Quote from WHO The only certain thing about Influenza is that nothing is certain 6